{"database": "lobbying", "table": "lobbying_activities", "rows": [[3706431, "a61624f2-b645-49d5-a42e-b372bc2fdcc7", "Q3", "IPOLICY SOLUTIONS", 401105127, "ASSOCIATION FOR MOLECULAR PATHOLOGY", 2025, "third_quarter", "MED", "No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2025-10-15T14:08:00-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3706431"], "units": {}, "query_ms": 0.2087110187858343, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}